NURO - NeuroMetrix, Inc.

4.58
0.220   4.803%

Share volume: 35,587
Last Updated: 05-01-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$4.36
0.22
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 25%
Dept financing 20%
Liquidity 30%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
5.29%
2 Year
17.44%
Key data
Stock price
$4.58
P/E Ratio 
0.00
DAY RANGE
$4.33 - $4.69
EPS 
-$4.90
52 WEEK RANGE
$4.26 - $4.69
52 WEEK CHANGE
$4.76
MARKET CAP 
8.043 M
YIELD 
N/A
SHARES OUTSTANDING 
2.026 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
0.64
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Shai N. Gozani
Region: US
Website: neurometrix.com
Employees: 20
IPO year: 2004
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

NeuroMetrix, Inc. engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy. Quell, a wearable device for symptomatic relief and management of chronic pain.

Recent news